Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Starling

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
Headache|June 7, 2022
Cutaneous heat and light-induced pain thresholds in post-traumatic headache attributed to mild traumatic brain injuryAmaal J Starling, Melissa M Cortez, Nicholas R Jarvis, et al.
Cancer Research|November 1, 1983
Immunohistochemical localization of prostate carcinoma-associated antigensG L Wright, M L Beckett, J J Starling, et al.
Animals : an Open Access Journal From MDPI|September 5, 2017
The Use of a Virtual Online Debating Platform to Facilitate Student Discussion of Potentially Polarising TopicsPaul D McGreevy, Vicky Tzioumis, Chris Degeling, et al.
The Journal of Headache and Pain|August 30, 2019
Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trialsRobert E Shapiro, Helen M Hochstetler, Ellen B Dennehy, et al.
The Journal of Headache and Pain|September 6, 2022
Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 studyRobert P Cowan, Michael J Marmura, Hans-Christoph Diener, et al.
The Pharmacogenomics Journal|April 9, 2024
Pharmacogenomic study-A pilot study of the effect of pharmacogenomic phenotypes on the adequate dosing of verapamil for migraine preventionYi-Chieh Chen, Han Wang, Jayawant N Mandrekar, et al.
Headache|May 3, 2024
Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders-A retrospective tolerability and safety studyChristopher C Anderson, Courtney R Iser, Ingrid L Hirte, et al.
Cancer Research|June 1, 1991
In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexesJ J Starling, R S Maciak, K L Law, et al.
Headache|January 12, 2023
Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trialAmaal J Starling, Robert P Cowan, Dawn C Buse, et al.
Headache|February 6, 2021
Real-world efficacy, tolerability, and safety of ubrogepantChia-Chun Chiang, Karissa N Arca, Rachel B Dunn, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Headache|June 7, 2022
Cutaneous heat and light-induced pain thresholds in post-traumatic headache attributed to mild traumatic brain injuryAmaal J Starling, Melissa M Cortez, Nicholas R Jarvis, et al.
Cancer Research|November 1, 1983
Immunohistochemical localization of prostate carcinoma-associated antigensG L Wright, M L Beckett, J J Starling, et al.
Animals : an Open Access Journal From MDPI|September 5, 2017
The Use of a Virtual Online Debating Platform to Facilitate Student Discussion of Potentially Polarising TopicsPaul D McGreevy, Vicky Tzioumis, Chris Degeling, et al.
The Journal of Headache and Pain|August 30, 2019
Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trialsRobert E Shapiro, Helen M Hochstetler, Ellen B Dennehy, et al.
The Journal of Headache and Pain|September 6, 2022
Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 studyRobert P Cowan, Michael J Marmura, Hans-Christoph Diener, et al.
The Pharmacogenomics Journal|April 9, 2024
Pharmacogenomic study-A pilot study of the effect of pharmacogenomic phenotypes on the adequate dosing of verapamil for migraine preventionYi-Chieh Chen, Han Wang, Jayawant N Mandrekar, et al.
Headache|May 3, 2024
Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders-A retrospective tolerability and safety studyChristopher C Anderson, Courtney R Iser, Ingrid L Hirte, et al.
Cancer Research|June 1, 1991
In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexesJ J Starling, R S Maciak, K L Law, et al.
Headache|January 12, 2023
Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trialAmaal J Starling, Robert P Cowan, Dawn C Buse, et al.
Headache|February 6, 2021
Real-world efficacy, tolerability, and safety of ubrogepantChia-Chun Chiang, Karissa N Arca, Rachel B Dunn, et al.
Pageof 16